omega-3 fatty acids may prevent stroke victims from having another one. Reuters reports:
In a study of people with high cholesterol who were taking a low dose of a cholesterol-lowering "statin," researchers found that adding EPA did not reduce the occurrence of a first stroke but did lower recurrence rates in those with a history of stroke.For more on strokes, check out DiseaseProof’s stroke category.
The finding, published in the journal Stroke, stems from a large study of patients with elevated cholesterol levels who were randomly assigned to a low dose of pravastatin or simvastatin daily alone or with 1800 milligrams daily of EPA for roughly 5 years.
Of the 9,326 patients in the EPA group, 485 had a history of stroke, as compared with 457 of the 9,319 patients in the no-EPA group.
Dr. Kortaro Tanaka of Toyama University Hospital and colleagues found that rates of first stroke were 1.3 percent and 1.5 percent in the EPA and no-EPA groups -- a nonsignificant difference.
However, there were far fewer second strokes in the EPA group. The recurrent stroke rates were 6.8 percent in the EPA group versus 10.5 percent in the no-EPA group -- a significant difference.